Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FAC infant formula, take two

This article was originally published in The Tan Sheet

Executive Summary

FDA's Food Advisory Committee will meet June 20-21 to discuss "scientific issues and principles involved in assessing and evaluating whether a 'new' infant formula supports normal physical growth in infants when consumed under its intended conditions of use." Meeting is second in a series to assess infant formula quality issues; first took place April 4-5 (1"The Tan Sheet" April 8, 2002, p. 3). FAC will meet at the Holiday Inn, 1000 Baltimore Ave., College Park, Md. For more information, contact CFSAN's Constance Hardy at (301) 436-1433...

You may also be interested in...

Infant formula meeting canceled

FDA Food Advisory Committee meeting on infant formula scheduled for June 20-21 was canceled due to unavailability of some speakers, agency says. Meeting was to be second in series on quality issues ("1The Tan Sheet" June 3, 2002, In Brief). Rescheduling is planned, but dates have yet to be determined...

Infant Formula Data Generalizations Inappropriate In Most Cases – FAC

Data on preterm infants should not be applied to term infants in the majority of cases, but exceptions may arise on an individual basis, FDA's Food Advisory Committee said April 4-5

The ICER Process: Allergan Engagement Improves Cost Effectiveness Rating For Ubrelvy

ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts